珠海都市网
您当前的位置 :首页 > 文传商讯 > 正文
Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk Claim for General Snus
2024年07月05日 00:01:29来源:作者:
【摘要】 A pioneer in modified risk products, Swedish Match was the first company to receive a modified risk marketing claim and is the first to advance through the FDA renewal processSwedish Match presented real-world evidence that shows the claim

A pioneer in modified risk products, Swedish Match was the first company to receive a modified risk marketing claim and is the first to advance through the FDA renewal process
Swedish Match presented real-world evidence that shows the claim is delivering on its promise to both reduce harm to individual tobacco users and benefit the health of the population as a whole and should be renewed
Swedish Match also asked the agency to consider adjusting the use of the claim to help switch more smokers and smokeless tobacco product consumers

STAMFORD, CT.--(BUSINESS WIRE)--Experts from Swedish Match USA, Inc., an affiliate of Philip Morris International Inc. (NYSE: PM) (PMI), presented to the Tobacco Products Scientific Advisory Committee (TPSAC) on June 26, 2024. The committee, comprised of independent scientific researchers, provides regulatory guidance to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products.

The half-day meeting was part of the FDA’s review of Swedish Match’s request to continue marketing General Snus products in the U.S. as Modified Risk Tobacco Products (MRTPs), and to expand permitted use of the reduced risk claim to reach, and transition, more legal-age smokers away from cigarettes.

Initially granted by FDA in October 2019, Swedish Match can communicate to legal age consumers that “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” Currently that message is accessible only on the General Snus website.

Swedish Match presented to the committee real-world evidence showing the claim is delivering on its promise to reduce harm to individual tobacco users and benefit the health of the population and should be renewed.

In its renewal submission, Swedish Match is seeking to expand use to additional lawful marketing channels, such as point-of-sale display and direct mail to age-verified consumers.

As FDA’s Center for Tobacco Products Director Brian King said when unveiling its new five-year strategic plan, this is a critical moment in the history of tobacco product regulation,” Gerry Roerty, General Counsel for Swedish Match, USA, Inc. said to committee members. The Center’s mission is to make smoking-related disease and death a part of America’s past and “today, together, we can meaningfully advance that goal,” Roerty told committee members.

During the meeting, representatives from Swedish Match and committee members discussed a range of scientific, technical, and consumer-communications topics. The company provided an overview of its responsible marketing practices and presented evidence and research demonstrating low levels of use by unintended populations.

General Snus is a smokeless tobacco product, traditionally produced in Sweden, that is non-fermented, and air cured. The modified risk products submitted for renewal include eight General Snus varieties that have been made available in the U.S. for more than a decade, and include:

  • General Snus Original (pouch)
  • General Snus Original (loose)
  • General Snus White (pouch)
  • General Snus Mint (pouch)
  • General Snus Wintergreen (pouch)
  • General Snus Mini Mint (pouch)
  • General Snus Classic Blend (pouch)
  • General Snus Nordic Mint (pouch)

Stacey Kennedy, President, Americas Region & CEO of PMI’s U.S. business said: “We are understandably proud of our commitment to a cigarette-free America, which is achievable much faster if policy is guided by science.” She continued, “America’s 28 million adult smokers have been bombarded with misinformation about smoke-free products, which can cause confusion and prolong the most harmful form of nicotine consumption—smoking. We look forward to continuing dialogue with the FDA as it continues to consider renewal of this modified risk authorization.”

In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion. Our ambition is that all those who would otherwise continue smoking abandon cigarettes and switch completely to scientifically substantiated smoke-free products as soon as possible. Regulatory policies and decisions can accelerate the speed and magnitude of this historic change.

Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of ending the sale of cigarettes.

Note to the editor

The General Snus products were first authorized as “appropriate for the protection of the public health” through the premarket tobacco product application process in 2015 following a PMTA submission earlier in that same year.

Since then, Swedish Match USA, Inc., has submitted eight annual reports over as many years, the last four of which were combined with MRTP annual reporting.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS devices and consumables and Swedish Match’s General Snus as Modified Risk Tobacco Products. As of December 31, 2023, PMI's smoke-free products were available for sale in 84 markets, and PMI estimates that approximately 33 million adults around the world use PMI's smoke-free products. Smoke-free business accounted for approximately 37% of PMI’s total full-year 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.

责任编辑: admin

看新闻,关注新闻

天猫网友:Paranoid. 偏执
评论:如果说回忆是毒药,那么忘记就是解药。

天涯网友:肆虐ヽ Ragingヽ
评论:请别说谎,因为你能骗到的,都是相信你的人。

腾讯网友:楓獨洎薸蓅
评论:今天情人节出去玩,卖花的小姑娘拉着我:“大哥哥,买花吧,一看就知道你是花心的人”……

其它网友:念旧 cunese
评论:每天都要做两件事情:晚上不想睡、早上不想起。

淘宝网友:WinNer丶怀念
评论:我要多念一点书,哪怕以后当流氓,那咱也是有文化的流氓。

网易网友:凝固旳悲伤※
评论:做一个单纯的人,走一段幸福的路。

百度网友:續寫這段情
评论:这么不要脸,这么没心没肺,你的体重应该会很轻吧

猫扑网友:凊薄悢傢妇囡
评论:有些人,认真的让你心疼,有些人,欠扁的让你牙疼

搜狐网友:光棍节的忧伤
评论:别叫我忘了你,我根本就没记住你

本网网友:Chafferer  迷心
评论:天气热得像个笑话,日子过得像句废话。

相关阅读
分享到:
版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!